denosumab April 12, 2017 denosumab Trade Name Xgeva Orphan Indication Patients with giant cell tumor of bone USA Market Approval USA USA Designation Date 2010-12-20 00:00:00 Sponsor Amgen, Inc.;One Amgen Center Drive;Thousand Oaks, California, 91320
